Chemed Co. (NYSE:CHE) Shares Sold by Independent Advisor Alliance

Independent Advisor Alliance trimmed its stake in shares of Chemed Co. (NYSE:CHE) by 2.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,254 shares of the company’s stock after selling 66 shares during the period. Independent Advisor Alliance’s holdings in Chemed were worth $1,355,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Thrivent Financial for Lutherans lifted its stake in Chemed by 300.3% in the 2nd quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock valued at $63,249,000 after buying an additional 87,449 shares in the last quarter. International Assets Investment Management LLC purchased a new position in shares of Chemed in the third quarter valued at approximately $437,150,000. Impax Asset Management Group plc boosted its stake in shares of Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after acquiring an additional 51,974 shares during the last quarter. Epoch Investment Partners Inc. increased its position in shares of Chemed by 22.1% during the second quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company’s stock worth $121,068,000 after purchasing an additional 40,358 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale raised its stake in Chemed by 34.5% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 154,579 shares of the company’s stock valued at $98,516,000 after purchasing an additional 39,633 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the transaction, the executive vice president now owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. This trade represents a 21.90 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,113 shares of company stock valued at $3,557,445 over the last quarter. 3.32% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Royal Bank of Canada lowered their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Friday, November 22nd.

Chemed Stock Up 0.3 %

Shares of CHE opened at $573.57 on Wednesday. The stock has a fifty day simple moving average of $578.95 and a two-hundred day simple moving average of $564.99. The company has a market capitalization of $8.63 billion, a PE ratio of 28.98, a price-to-earnings-growth ratio of 2.42 and a beta of 0.46. Chemed Co. has a 52-week low of $523.33 and a 52-week high of $654.62.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. During the same period last year, the firm earned $5.32 earnings per share. Chemed’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, equities analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be given a $0.50 dividend. The ex-dividend date is Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.35%. Chemed’s payout ratio is 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.